12 24

Cited 0 times in

p53 유전자 변형이 발생한 위암세포주에서 유전자이상 교정에 의한 항암제 감수성 변화

DC FieldValueLanguage
dc.contributor.author노재경-
dc.contributor.author라선영-
dc.contributor.author유내춘-
dc.contributor.author정현철-
dc.contributor.author라선영-
dc.contributor.author유내춘-
dc.contributor.author정현철-
dc.date.accessioned2020-07-02T17:25:59Z-
dc.date.available2020-07-02T17:25:59Z-
dc.date.issued1998-
dc.identifier.issn0496-6872-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/176810-
dc.description.abstractPURPOSE: It has been theorized that p53 may be involved in the sensitivity to chemotherapeutic agents. We evaluated the chemosensitivity of wild p53 after transduction into gastric cancer cell lines with mutant p53. MATERIALS AND METHODS: YCC-3(parent cell line with mutant p53), YCC-3v(parent cell line transduced with vector alone) and YCC-3C3(clone with wild p53) cell lines were used in this study. p53 protein expression was measured by ELISA assay. Tumorigenicity and drug sensitivity were evaluated by soft agar and proliferation assay, respectively. Cell cycle analysis was performed by flowcytometry. Telomerase activity was measured by TRAP assay and terminal restriction fragment(TRF) length was measured after Southern blot analysis. RESULTS: Even though p53 production from the YCC-3C3 cell line was three times higher than those of YCC-3 and YCC-3v cell lines, the cell cycle was the same in these three cell lines. In the YCC-3C3 cell line, drug sensitivity to etoposide and cisplatin was increased when we compared it to those of the YCC-3v cell line(etoposide, 50% versus 83%; cisplatin, 67% versus 83%). However, there was no chemo-sensitization effect with vincristine, vinblastine and carboplatin. After exposure to cisplatin, a G0/G1 check-point effect was found in the YCC-3C3 cell line, but not in the YCC-3v cell line. No differences were found in telomerase activity, TRFs length or DNA fragmentation between the YCC-3v and YCC-3C3 cell lines after cisplatin treatment. CONCLUSION: Wild-type p53 gene transduction in the gastric cancer cell line induced sensitization to the cytotoxicity of etoposide and cisplatin. This suggests the possible application of combined chemo-gene therapy with an EP regimen and wild-type p53 in gastric cancer patients with p53 mutation.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean-
dc.publisher대한암학회-
dc.relation.isPartOfJournal of the Korean Cancer Association (대한암학회지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titlep53 유전자 변형이 발생한 위암세포주에서 유전자이상 교정에 의한 항암제 감수성 변화-
dc.title.alternativeRestoration of Wild - type p53 Induces Chemo-sensitization in the Gastric Cancer Cell Line with Mutant p53-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthor맹호영-
dc.contributor.googleauthor라선영-
dc.contributor.googleauthor민병소-
dc.contributor.googleauthor김용배-
dc.contributor.googleauthor곽현주-
dc.contributor.googleauthor김태수-
dc.contributor.googleauthor박규현-
dc.contributor.googleauthor유내춘-
dc.contributor.googleauthor임호영-
dc.contributor.googleauthor최진혁-
dc.contributor.googleauthor김주항-
dc.contributor.googleauthor노재경-
dc.contributor.googleauthor민진식-
dc.contributor.googleauthor김병수-
dc.contributor.googleauthor정현철-
dc.contributor.localIdA01290-
dc.contributor.localIdA01316-
dc.contributor.localIdA01316-
dc.contributor.localIdA02457-
dc.contributor.localIdA02457-
dc.contributor.localIdA03773-
dc.contributor.localIdA03773-
dc.contributor.localIdA01316-
dc.contributor.localIdA01316-
dc.contributor.localIdA02457-
dc.contributor.localIdA02457-
dc.contributor.localIdA03773-
dc.contributor.localIdA03773-
dc.relation.journalcodeJ01813-
dc.subject.keywordWild-type p53-
dc.subject.keywordChemo-sensitization-
dc.subject.keywordEtoposide-
dc.subject.keywordCisplatin-
dc.subject.keywordGastric cancer-
dc.contributor.alternativeNameRoh, Jae Kyung-
dc.contributor.affiliatedAuthor노재경-
dc.contributor.affiliatedAuthor라선영-
dc.contributor.affiliatedAuthor라선영-
dc.contributor.affiliatedAuthor유내춘-
dc.contributor.affiliatedAuthor유내춘-
dc.contributor.affiliatedAuthor정현철-
dc.contributor.affiliatedAuthor정현철-
dc.contributor.affiliatedAuthor라선영-
dc.contributor.affiliatedAuthor라선영-
dc.contributor.affiliatedAuthor유내춘-
dc.contributor.affiliatedAuthor유내춘-
dc.contributor.affiliatedAuthor정현철-
dc.contributor.affiliatedAuthor정현철-
dc.citation.volume30-
dc.citation.number4-
dc.citation.startPage497-
dc.citation.endPage507-
dc.identifier.bibliographicCitationJournal of the Korean Cancer Association (대한암학회지), Vol.30(4) : 497-507, 1998-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.